LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
63 hedge funds and large institutions have $69.8M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
11
Reduced
16
Closed
19
Calls
$5K
Puts
$7K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
SCM
1
Sio Capital Management
New York
|
$811K |
| 2 |
2
Renaissance Technologies
New York
|
$428K |
| 3 |
3
Millennium Management
New York
|
$419K |
| 4 |
TEE
4
Tibra Equities Europe
London,
United Kingdom
|
$340K |
| 5 |
E
5
Ergoteles
New York
|
$297K |
